Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,174 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

NCT00685412

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +21 more
Locations
  • Lyndhurst Gynecologic Associates Winston-Salem, North Carolina, United States
  • Laurel Highlands, OB/GYN, P.C. Hopwood, Pennsylvania, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Clinical Research Puerto Rico San Juan, Puerto Rico
View Trial Details
Completed

Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C

NCT00512278

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Cedars-Sinai Medical Center, Center for Liver Disease and Transplantation Los Angeles, California, United States
  • Advanced Medical Research Center Port Orange, Florida, United States
  • University of Louisville Louisville, Kentucky, United States
  • Case Medical Center Cleveland, Ohio, United States
View Trial Details
Completed

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701

NCT00453440

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Woolwich, London, London, United Kingdom
  • GSK Investigational Site Birmingham, Warwickshire, United Kingdom
  • GSK Investigational Site Birmingham, United Kingdom
  • GSK Investigational Site London, United Kingdom
View Trial Details
Completed

A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA

NCT00693186

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Unità Operativa Semplice di Epidemiologia (UOSE) Quarto, Napoli, Italy
  • Azienda per i Servizi Sanitari n. 5 "Bassa Friulana" Latisana, Udine, Italy
  • Ospedale Maggiore di Modica - Via Resistenza Partigiana (c/o Ospedale Maggiore) Modica, Italy
  • AUSL n. 7 di Ragusa Servizio di Epidemiologia Via G. Di Vittorio 59/c Ragusa, Italy
View Trial Details
Completed

Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA

NCT02012998

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Sanofi Pasteur MSD Investigational Site 004 Bologna, Italy
  • Sanofi Pasteur MSD Investigational Site 009 Cagliari, Italy
  • Sanofi Pasteur MSD Investigational Site 005 Capannori, Italy
  • Sanofi Pasteur MSD Investigational Site 003 Chiavari, Italy
View Trial Details

Related conditions